Denmark-based, Tetra Pharm Technologies (TPT) is a biotech startup committed to treat neuropathic pain & mental health disorders, by “designing & developing new drug formulations/ candidates, conducting clinicals & commercializing medicines targeting the endocannabinoid system (ECS)”. <Quick primer on the ECS: it regulates & controls many critical body functions such as, via CB1 receptors (found mostly in the brain) - learning & memory, emotional processing, sleep, temperature control, pain control, & via CB2 receptors (found mostly in tissue) - inflammatory & immune responses >. Worth keeping mind, the European market for cannabinoid-based treatment is expected to reach €3.2b by 2025. TPT is said to have closed “several significant distribution deals” across main European markets &...

France-based PASQAL is quantum computing startup <quick primer on quantum computers: instead of bits, which conventional computers use, a quantum computer uses quantum bits – known as qubits. To illustrate the difference, imagine a sphere. A bit can be at either of the two poles of the sphere (0,1), but a qubit can exist at any point on the sphere (0,1 &/ 1,0). So, this means that a quantum computer can store an enormous amount of info & uses less energy to so (as it can operate at room temperature) vs a classical computer>. Now onto the good stuff… What makes PASQAL stand out is that the startup is betting on “neutral atoms quantum computing”....